When compared to healthy control subjects, some patients with dopamine-dependent disorders (e.g., Parkinson’s disease or schizophrenia) have abnormal peripheral (plasma) and central (cerebrospinal fluid) OXT levels as well as fewer OXT+ neurons in the hypothalamus (in post-mortem tissue) [143]. The gene discussed is OXT; the disease is Parkinson disease.